Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GSK)
NYSE:GSK
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 31.95B | £ 31.38B | £ 30.33B | £ 29.32B | £ 24.70B |
| Gross Profit | £ 23.18B | £ 22.33B | £ 21.76B | £ 19.77B | £ 16.53B |
| Operating Income | £ 7.01B | £ 4.02B | £ 6.75B | £ 6.43B | £ 4.36B |
| EBITDA | £ 11.62B | £ 6.67B | £ 9.08B | £ 8.60B | £ 6.49B |
| Net Income | £ 5.59B | £ 2.58B | £ 4.93B | £ 14.96B | £ 4.38B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 3.40B | £ 3.71B | £ 6.61B | £ 7.88B | £ 5.87B |
| Total Assets | £ 61.01B | £ 59.46B | £ 75.22B | £ 60.15B | £ 107.14B |
| Total Debt | £ 17.69B | £ 16.99B | £ 22.97B | £ 20.99B | £ 32.74B |
| Net Debt | £ 14.30B | £ 13.29B | £ 19.23B | £ 17.26B | £ 26.95B |
| Total Liabilities | £ 45.02B | £ 46.38B | £ 58.91B | £ 50.05B | £ 78.23B |
| Stockholders' Equity | £ 16.35B | £ 13.67B | £ 17.01B | £ 10.60B | £ 20.39B |
| Cash Flow | |||||
| Free Cash Flow | £ 5.82B | £ 3.57B | £ 6.26B | £ 6.75B | £ 5.30B |
| Operating Cash Flow | £ 7.14B | £ 6.55B | £ 7.89B | £ 8.16B | £ 7.95B |
| Investing Cash Flow | £ -5.72B | £ -1.23B | £ -2.40B | £ -10.88B | £ -1.78B |
| Financing Cash Flow | £ -1.59B | £ -4.73B | £ -6.07B | £ 2.05B | £ -7.59B |